Last reviewed · How we verify
RN564 (rn564)
At a glance
| Generic name | rn564 |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 1 |
Approved indications
Common side effects
- Eye pruritus
- Abnormal faeces
- Gingival pain
- Fatigue
- Ligament sprain
- Muscle spasms
- Dizziness postural
- Headache
- Tension headache
- Haematuria
- Hypertension
- Anaemia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RN564 CI brief — competitive landscape report
- RN564 updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI